Photo from archive.org
The MDM2 inhibitor MK-8242 is tolerable in patients with liposarcoma and other advanced solid tumors. Click to show full abstract
The MDM2 inhibitor MK-8242 is tolerable in patients with liposarcoma and other advanced solid tumors.
Keywords:
solid tumors;
advanced solid;
p53 wild;
active patients;
8242 active;
patients p53
Journal Title: Cancer discovery
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer discovery
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!